Akari Therapeutics Plc (AKTX) ADR EACH REPR 80000 ORD SPON

Sell:0.00pBuy:0.00pPrice unchangedNo change

Prices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open-
Previous close-
Market cap-
P/E ratio-99999.99
Volume-
Dividend yield0.00%
EMS-

Company information

Akari Therapeutics, Plc is a biotechnology company developing precision bifunctional antibody drug conjugates (ADC) for the treatment of cancer. Utilizing its ADC discovery platform, it generates bifunctional ADC ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBX
  • Shares in issue0.00
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.